Elsevier

Clinical Imaging

Volume 39, Issue 1, January–February 2015, Pages 66-71
Clinical Imaging

Original Article
Hepatobiliary phase of gadoxetic acid-enhanced MR in patients suspected of having gallbladder dyskinesia: comparison with hepatobiliary scintigraphy

https://doi.org/10.1016/j.clinimag.2014.08.009Get rights and content

Abstract

Objective

To compare hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance (HMR) and hepatobiliary scintigraphy (HBS) for evaluation of cystic duct patency and gallbladder contractility in patients suspected of having gallbladder dyskinesia.

Materials and methods

Eighteen patients underwent HMR and HBS. Cystic duct patency and gallbladder ejection fraction (GBEF) were compared to determine a significant difference between HMR and HBS.

Results

HMR and HBS had 15 concordant and 3 discordant results for cystic duct patency. GBEF in eight patients showed no significant difference between both modalities.

Conclusion

HMR may be an alternative to HBS for the functional evaluation of cystic duct patency and GBEF.

Introduction

Hepatobiliary scintigraphy (HBS) has been an unchallenged modality for the functional evaluation of the gallbladder. In the clinical evaluation of a patient presenting with right upper quadrant tenderness and equivocal imaging findings for acute cholecystitis, HBS has played an important role by demonstrating the functional evaluation of cystic duct patency and gallbladder contractility [1], [2]. The functional information of gallbladder is useful for the diagnosis of acute cholecystitis and other functional gallbladder diseases such as gallbladder dyskinesia that frequently manifests as biliary colic mimicking acute cholecystitis and has traditionally been evaluated by assessment of gallbladder contractility based on the ejection fraction [3], [4], [5]. Magnetic resonance (MR) cholangiography using mangafodipir trisodium for the evaluation of cystic duct patency and gallbladder contractility measurement by ultrasound (US) have been reported [5], [6] however not widely accepted. Recently, commercial availability of hepatobiliary specific gadolinium-based MR contrast agent has been increasing, and MR using a gadolinium agent with a higher rate of hepatobiliary excretion has shown promise as an alternative to HBS for the functional evaluation of gallbladder [7], [8], [9]. MR including the hepatobiliary phase may be able to provide functional and morphological information on the gallbladder simultaneously. In this study, we prospectively compared the hepatobiliary phase of gadoxetic acid-enhanced MR with HBS for the evaluation of cystic duct patency and gallbladder contractility in patients suspected of having gallbladder dyskinesia.

Section snippets

Patients

This study was approved by our institutional review board, and written informed consent was obtained from all participants prior to entering the study. Between April 2008 and December 2010, 18 consecutive patients (8 men and 10 women; age range, 16–83 years; mean age, 50.6 years) were enrolled in this study prospectively. The inclusion criteria were as follows: (a) Patients that had a sudden onset of right upper quadrant tenderness, (b) patients that showed equivocal findings for acute

Diagnostic performance of MR and HBS

All patients showed biliary and duodenal excretion at the hepatobiliary phase of gadoxetic acid-enhanced MR and did not show cystic or common duct obstruction at T2-weighed MR. In total, 15 patients demonstrated concordant results at the hepatobiliary phase MR and HBS (Table 2). Of these, five showed no reflux of contrast and radiotracer into the gallbladder at the hepatobiliary phase MR and HBS, respectively. Two of the five improved by conservative treatment. Three patients underwent a

Discussion

Gallbladder dyskinesia refers to the clinical entity of right upper quadrant symptoms of biliary colic and abnormal GBEF in the absence of gallstones or sludge [3]. Terminology can be confusing and numerous other names have been used for this entity (i.e., chronic acalculous cholecystitis, cystic duct syndrome, functional gallbladder disease, and so on) [10]. The functional biliary pain is most often attributed to abnormal gallbladder motility [4]. The diagnosis and treatment of gallbladder

Acknowledgments

This research was supported by Research Grant of Bayer Korea Ltd. (ISS#13658).

References (19)

There are more references available in the full text version of this article.

Cited by (7)

View all citing articles on Scopus
View full text